Synaxys realizes preclinical assays and R&D projects to rapidly predict the response of the human nervous system before starting clinical trials. Using our proprietary 5D-brain models, we propose custom pharmacology and toxicology screens and electrophysiological assays on neural functions to identify the targets and actions of a compound. 5D-brain models are long lived, composed of all the neuronal cell types and bring pertinent data on Epilepsy, Parkinson, Multiple Sclerosis, Autism, Alzheimer

SYNCROSOME is an innovative preclinical CRO with relevant disease models we offer robust drug efficacy data and high value interpretation to assist drug discovery companies in evaluating the potential of their therapeutic compounds. We provide more than 15 predictive animal models of pathology in CNS, cardiovascular, gastroenterology, respiratory and metabolic disorders.

The Syneos Health Translational Science Team consists today of 80+ seasoned Scientist co-located in one site embedded in a Bio-Park in SE France, and works on a Laboratory space of about 2,900 m2, with more than 200 pieces of state-of-the-art equipment. Our sound cumulative expertise of Pharmaceutical Development enables us to have a clear knowledge of pharmaceutical projects, development hurdles and the vision to take into account risks mitigation factors in the sequence for success.

Based in Lille (France) X’PROCHEM is a biotech company with proprietary chemical technology platform, which helps its bio-pharma partners design and create therapeutic, vaccine and diagnostic mid-size proteins. Our vison is to make today’s and tomorrow’s bio-pharmaceuticals better and more accessible.

Xell is an innovative and agile partner for the biotech and pharmaceutical industry, providing highly efficient solutions in cell culture technology. Besides our dedicated focus on cell culture media development, we have also strengthened our proprietary technology.

Successful projects e.g. improving process efficiency, yields and quality in biopharmaceutical production for customers as BeiGene, Boehringer Ingelheim or Sanofi, CMOs SMEs, have helped us gain a reputation as reliable partner.

XPECT-INX® is a spin-off project of Ghent University (Belgium). By developing and offering high quality bioinks and biomaterials, we aim to be your support in bioprinting to bring tissue engineering and regenerative medicine closer to clinical reality! To do so we provide researchers, clinicians and industry the unique tools for break-through research. Please enquire if you require a specific (custom) bioink or biomaterial ink for your application.

Zoetis is currently the leading animal health company globally. We discover, develop, manufacture and commercialize medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals in more than 100 countries.